Atypical hemolytic uremic syndrome: genetically-based insights into pathogenesis through an analysis of the complement regulator CD46
Annals of Blood · 2023-09 · 8 · 27-27
DOI: 10.21037/aob-22-40 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Blood, 2023-09. Verfasst von Xiaobo Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Rheumatology, Washington University School of Medicine, St. Louis, MO, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, NIAMS NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Division of Rheumatology, Washington University School of Medicine, St. Louis, MO, USA.
- Division Nephrology, Washington University School of Medicine, St. Louis, MO, USA.
Förderung
- NEI NIH HHS
- NIAMS NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Wu, X., Liszewski, M. K., Java, A., & Atkinson, J. P. (2023). Atypical hemolytic uremic syndrome: genetically-based insights into pathogenesis through an analysis of the complement regulator CD46. Annals of Blood, 8, 27-27. https://doi.org/10.21037/aob-22-40
Vancouver
Wu X, Liszewski MK, Java A, Atkinson JP. Atypical hemolytic uremic syndrome: genetically-based insights into pathogenesis through an analysis of the complement regulator CD46. Annals of Blood. 2023;8:27-27. doi:10.21037/aob-22-40
BibTeX
@article{Wu2023,
author = {Wu, Xiaobo and Liszewski, M Kathryn and Java, Anuja and Atkinson, John P},
title = {Atypical hemolytic uremic syndrome: genetically-based insights into pathogenesis through an analysis of the complement regulator CD46},
journal = {Annals of Blood},
year = {2023},
volume = {8},
pages = {27--27},
doi = {10.21037/aob-22-40}
}
EUVIMED